On October 15, 2026, Nordicus Partners Corporation issued a promissory note to ABCHill Holding ApS for $147,000. The lender is wholly owned by Christian Hill-Madsen, who serves as CEO of subsidiary NP Bioinnovation A/S and COO of NoviThera ApS, and is also a director of subsidiaries Orocidin A/S and Bio-Convert A/S. The note bears interest at the lesser of 6.0% per annum or the maximum legal rate, is payable on demand, and may be prepaid without penalty. This transaction represents a related-party loan filed under Item 1.01 and Item 2.03.
Nordicus Partners Corporation operates as a holding company focused on investments in biotechnology and life sciences companies.
